/r/Microbiomestocks
Discussion of investments related to the microbiome
Welcome to Microbiome Stocks!
A community that encourages good investing practices, this sub-reddit intends to educate and prepare investors for the rise of microbiome therapeutics. The microbiome is an overlooked area with great potential for improving human health. Please subscribe and contribute anything that relates to microbiome investing.
Breaking any of the following rules is grounds for having your post/comment removed
Be respectful and kind
Titles must be descriptive, no click-bait titles, use article's actual title in post's wherever possible.
Posts must have a clear connection to the microbiome and microbiome industry
/r/Microbiomestocks
273 Subscribers
Challenges in Microbiome Therapeutics
Celine Druart, Executive Director, Pharmabiotic Research Institute (PRI) offered her insight into the primary challenges faced in translating microbiome research into effective therapeutic interventions.
She writes “Translating microbiome research into effective therapeutic interventions is a complex endeavor that faces several significant challenges, with regulatory uncertainty being a major obstacle. Microbiome-based therapies often involve living organisms, which do not align neatly with traditional categories of drugs or biologics. Regulatory agencies such as the FDA, EMA, and MHRA are actively refining guidelines to assess these therapies’ safety, efficacy, and quality.
Additionally, the regulatory framework is undergoing significant changes, such as the introduction of the new Substances of Human Origin (SoHO) Regulation. This regulation will include human microbiomes within its scope, representing a major shift that will profoundly impact human microbiome research and development. These changes create uncertainties and introduce additional hurdles for researchers and companies as they navigate the development and approval processes for microbiome-based therapies.”
11:55 UTC
Isolating probiotic bacteria from different human locations including skin
Read more insights from Eric (Chun-Ming) Huang's
https://global-engage.com/resource-center/microbiome-insights/
10:44 UTC
Absolute Newbie has Stupid Questions, many: fmt, ms, dead researcher, missing entry on cv
Hi...sooooo....I've been running through rabbit holes (there are none left, I got them all) reading about FMT and MS, from many perspectives...science and business and I noticed something odd. Please correct if nec, but in 2011 T. Brody, of an Australian Centre, published three case histories of remarkable recoveries from MS because of FMT. In May of 2022, the first major attempt to replicate that success is half shut down because the PI suddenly dies! I can't find anything on that that them: MK. And then I checked T.Brody's website and no mention of the 2011 case studies....I know there's a lot I'm missing. Can anyone fill me in?
I really did set out to get an idea of what to buy. Unfortunately, I bought Seres when it was much higher than it is, sadly, today. But it doesn't matter, because I'm in it for the long haul, aiming high. I'd really like to be there, kind of see it, when MS goes down. A.
02:34 UTC